Gregory Jaye Bix

• Tulane University of Louisiana

  Director

Sources: reporter.nih.gov

• National Institute on Aging

  R01, Investigating the role and therapeutic potential of the alpha5beta1 integrin in risk factors for COVID-19-associated cognitive impairment, R01AG078677, 2023–2028, 6 Apr 2026

• National Institute of Neurological Disorders and Stroke

  RF1, Investigating the Role and the therapeutic potential of Perlecan in experimental vascular dementia, RF1NS136861, 2024–2027, 12 Jun 2024

• National Institute on Aging

  RF1, Investigating the role of Alpha5Beta1 integrin in cognitive dysfunction, RF1AG078677, 2023–2026, 28 May 2024

• National Institute of Neurological Disorders and Stroke

  R01, Combination treatment of ischemic stroke with perlecan DV and neural stem cells, R01NS110370, 2023–2025, 5 Mar 2024

Sources: reporter.nih.gov